← Leaderboards
Zijian Xie
University Of Toledo Health Sci Campus
$8,165,281
Attributed
$9,267,459
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $982.6K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$9,267,459 · 7
By mechanism
R01$5,555,739 · 4
P01$3,711,720 · 3
Top collaborators
- Joseph Isaac Shapiro4 shared
Most similar at University Of Toledo Health Sci Campus
Same institution · by research overlap
- Amir Askari$3,435,700
- Sandrine V Pierre$2,625,826
- Lijun Catherine Liu$727,955
- Jiang Tian$1,841,416
- Joseph Isaac Shapiro$1,102,178
Others in their field
Top investigators on “Ouabain”
- Mordecai P Blaustein · University Of Maryland Baltimore$6,351,413
- V Gustavo Blanco · University Of Kansas Lawrence$6,084,077
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$4,591,413
- Hainan Lang · Medical University Of South Carolina$3,965,929
- Jerry B Lingrel · University Of Cincinnati$3,867,584
- David C Gadsby · Rockefeller University$3,338,899
Research focus
OuabainTissue /Cell CultureCardiac GlycosidesProtein KinaseNa(+)-K(+)-Exchanging AtpaseBinding (Molecular Function)ProteinsAbbreviationsBasePlayProtein Kinase C1-Phosphatidylinositol 3-KinaseReactive Oxygen SpeciesSodium Potassium Exchanging AtpaseSignal TransductionReceptorComplexRegulationBlood PressureEndocytosisFunctional DisorderCardiac MyocytesReceptor FunctionProtein Tyrosine Kinase
Grant awards (33)
Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac Diseases$535,678
R01 · FY2014 · HL · contact PI
Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac Diseases$537,347
R01 · FY2013 · HL · contact PI
Interaction of Na+/K+-ATPase With It's Signaling Partners$276,718
P01 · FY2013 · HL · contact PI
Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac Diseases$564,441
R01 · FY2012 · HL · contact PI
Interaction of Na+/K+-ATPase With It's Signaling Partners$290,670
P01 · FY2012 · HL · contact PI
Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac Diseases$566,890
R01 · FY2011 · HL · contact PI
Interaction of Na+/K+-ATPase With It's Signaling Partners$290,670
P01 · FY2011 · HL · contact PI
Interaction of Na+/K+-ATPase With It's Signaling Partners$305,304
P01 · FY2010 · HL · contact PI
Na,K-ATPase as an Integrator of the Calcium-signaling Machinery$271,611
R01 · FY2010 · GM · contact PI
Interaction of Na+/K+-ATPase With It's Signaling Partners$296,412
P01 · FY2009 · HL · contact PI
Na,K-ATPase as an Integrator of the Calcium-signaling Machinery$295,008
R01 · FY2009 · GM · contact PI
Na,K-ATPase as an Integrator of the Calcium-signaling Machinery$323,661
R01 · FY2008 · GM · contact PI
Na,K-ATPase as an Integrator of the Calcium-signaling Machinery$42,543
R01 · FY2008 · GM · contact PI
CORE--PREPARATIVE FACILITIES$420,401
P01 · FY2007 · HL · contact PI
Interactions of Na+/K+ ATPase with its signaling partners$287,797
P01 · FY2007 · HL · contact PI
Na,K-ATPase as an Integrator of the Calcium-signaling Machinery$274,355
R01 · FY2007 · GM · contact PI
The Role of ROS and Na/K-ATPase in Uremic Cardiomyopathy$251,205
R01 · FY2006 · HL · contact PI
CORE--PREPARATIVE FACILITIES$357,360
P01 · FY2005 · HL
The Role of ROS and Na/K-ATPase in Uremic Cardiomyopathy$257,250
R01 · FY2005 · HL
Interactions of Na+/K+ ATPase with its signaling partners$227,224
P01 · FY2005 · HL
The Role of ROS and Na/K-ATPase in Uremic Cardiomyopathy$257,250
R01 · FY2004 · HL
The Role of ROS and Na/K-ATPase in Uremic Cardiomyopathy$257,250
R01 · FY2003 · HL
REGULATION OF SODIUM PUMP GENE EXPRESSION$216,000
R01 · FY2003 · HL
CONTROL OF CARDIAC GROWTH BY CARDIAC GLYCOSIDES$321,374
P01 · FY2002 · HL
CORE--PREPARATIVE FACILITIES$321,374
P01 · FY2002 · HL
The Role of ROS and Na/K-ATPase in Uremic Cardiomyopathy$257,250
R01 · FY2002 · HL
REGULATION OF SODIUM PUMP GENE EXPRESSION$216,000
R01 · FY2002 · HL
REGULATION OF SODIUM PUMP GENE EXPRESSION$216,000
R01 · FY2001 · HL
CONTROL OF CARDIAC GROWTH BY CARDIAC GLYCOSIDES$0
P01 · FY2001 · HL
CORE--PREPARATIVE FACILITIES$0
P01 · FY2001 · HL
REGULATION OF SODIUM PUMP GENE EXPRESSION$216,000
R01 · FY2000 · HL
CORE--PREPARATIVE FACILITIES$158,208
P01 · FY2000 · HL
CONTROL OF CARDIAC GROWTH BY CARDIAC GLYCOSIDES$158,208
P01 · FY2000 · HL